Selective COX-2 inhibitors: a promise unfulfilled?
Henry
David
D
McGettigan
Patricia
P
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000139:chemically induced; D052246:Cyclooxygenase 2 Inhibitors / Q000009:adverse effects*; D004347:Drug Interactions; D004381:Duodenal Ulcer / Q000139:chemically induced* / Q000382:microbiology; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced; D016481:Helicobacter Infections / Q000382:microbiology; D006801:Humans; D010437:Peptic Ulcer / Q000139:chemically induced* / Q000382:microbiology; D010438:Peptic Ulcer Hemorrhage / Q000139:chemically induced* / Q000382:microbiology; D010439:Peptic Ulcer Perforation / Q000139:chemically induced*; D018570:Risk Assessment; D012307:Risk Factors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors